Twilio Inc vs GeneDx Holdings Corp — how do they compare? Twilio Inc trades at $195.99 (market cap $31.15B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Twilio Inc is far larger — about 17.3× GeneDx Holdings Corp's market cap, and Twilio Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| TWLO | WGS | |
|---|---|---|
Market Cap | $31.15B | $1.80B |
Sector | Technology | Technology |
52-Week High | $236.64 | $167.51 |
52-Week Low | $92.44 | $34.51 |
Enterprise Value | $29.87B | $1.80B |
Trailing returns across standard periods
Latest headlines on both assets
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →